These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21086905)

  • 1. C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis.
    Sweiss NJ; Barnathan ES; Lo K; Judson MA; Baughman R;
    Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):49-56. PubMed ID: 21086905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
    Baughman RP; Drent M; Kavuru M; Judson MA; Costabel U; du Bois R; Albera C; Brutsche M; Davis G; Donohue JF; Müller-Quernheim J; Schlenker-Herceg R; Flavin S; Lo KH; Oemar B; Barnathan ES;
    Am J Respir Crit Care Med; 2006 Oct; 174(7):795-802. PubMed ID: 16840744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The St. George's Respiratory Questionnaire in Pulmonary Sarcoidosis.
    Lo KH; Donohue J; Judson MA; Wu Y; Barnathan ES; Baughman RP;
    Lung; 2020 Dec; 198(6):917-924. PubMed ID: 32979072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial.
    Judson MA; Baughman RP; Costabel U; Mack M; Barnathan ES
    Respir Med; 2014 Jan; 108(1):189-94. PubMed ID: 24361164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial.
    Baughman RP; Judson MA; Lower EE; Drent M; Costabel U; Flavin S; Lo KH; Barnathan ES;
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):289-95. PubMed ID: 26847095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis.
    Drake WP; Culver DA; Baughman RP; Judson MA; Crouser ED; James WE; Ayers GD; Ding T; Abel K; Green A; Kerrigan A; Sesay A; Bernard GR
    Chest; 2021 May; 159(5):1902-1912. PubMed ID: 33387486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
    Lower EE; Harman S; Baughman RP
    Chest; 2008 May; 133(5):1189-95. PubMed ID: 18263672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of C-reactive protein and clinically relevant baseline variables in sarcoidosis.
    McDonnell MJ; Saleem MI; Wall D; Gilmartin JJ; Rutherford RM; O'Regan A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):331-340. PubMed ID: 28079845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I.
    Reinisch W; Wang Y; Oddens BJ; Link R
    Aliment Pharmacol Ther; 2012 Mar; 35(5):568-76. PubMed ID: 22251435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.
    Rennard SI; Fogarty C; Kelsen S; Long W; Ramsdell J; Allison J; Mahler D; Saadeh C; Siler T; Snell P; Korenblat P; Smith W; Kaye M; Mandel M; Andrews C; Prabhu R; Donohue JF; Watt R; Lo KH; Schlenker-Herceg R; Barnathan ES; Murray J;
    Am J Respir Crit Care Med; 2007 May; 175(9):926-34. PubMed ID: 17290043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis.
    Rossman MD; Newman LS; Baughman RP; Teirstein A; Weinberger SE; Miller W; Sands BE
    Sarcoidosis Vasc Diffuse Lung Dis; 2006 Oct; 23(3):201-8. PubMed ID: 18038919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-minute walk test and health status assessment in sarcoidosis.
    Baughman RP; Sparkman BK; Lower EE
    Chest; 2007 Jul; 132(1):207-13. PubMed ID: 17625083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial.
    Judson MA; Baughman RP; Costabel U; Flavin S; Lo KH; Kavuru MS; Drent M;
    Eur Respir J; 2008 Jun; 31(6):1189-96. PubMed ID: 18256069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
    Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
    Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
    Sweiss NJ; Noth I; Mirsaeidi M; Zhang W; Naureckas ET; Hogarth DK; Strek M; Caligiuri P; Machado RF; Niewold TB; Garcia JG; Pangan AL; Baughman RP
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Apr; 31(1):46-54. PubMed ID: 24751453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of infliximab on refractory sarcoidosis.
    Ørum M; Hilberg O; Krag S; Bendstrup E
    Dan Med J; 2012 Dec; 59(12):A4535. PubMed ID: 23290282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation.
    Baughman RP; Shipley R; Desai S; Drent M; Judson MA; Costabel U; du Bois RM; Kavuru M; Schlenker-Herceg R; Flavin S; Lo KH; Barnathan ES;
    Chest; 2009 Aug; 136(2):526-535. PubMed ID: 19395578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
    Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab therapy in pulmonary sarcoidosis.
    Kähler CM; Heininger P; Loeffler-Ragg J; Vogelsinger H
    Am J Respir Crit Care Med; 2007 Aug; 176(4):417; author reply 417-8. PubMed ID: 17675452
    [No Abstract]   [Full Text] [Related]  

  • 20. High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment.
    Magro F; Rodrigues-Pinto E; Santos-Antunes J; Vilas-Boas F; Lopes S; Nunes A; Camila-Dias C; Macedo G
    J Crohns Colitis; 2014 Feb; 8(2):129-36. PubMed ID: 23932786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.